Merck
MRK
#71
Rank
$209.62 B
Marketcap
$83.48
Share price
-0.23%
Change (1 day)
-34.84%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): $6.90

According to Merck's latest financial reports the company's current EPS (TTM) is $6.90. In 2024 the company made an earnings per share (EPS) of $6.76 an increase over its 2023 EPS that were of $0.15.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$6.902.04%
2024$6.764308.46%
2023$0.15-97.32%
2022$5.7310.92%
2021$5.1784.68%
2020$2.80-27.2%
2019$3.8463.44%
2018$2.35151.11%
2017$0.94-54.58%
2016$2.0630.21%
2015$1.58-61.99%
2014$4.16180.51%
2013$1.48-31.82%
2012$2.186.62%
2011$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.39-79.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$9.07 31.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$12.36 79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$2.68-61.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.85-58.72%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
$1.56-77.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
-$1.14-116.53%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$6.43-6.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
$7.79 12.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.05 60.21%๐Ÿ‡บ๐Ÿ‡ธ USA